Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Search Results to Slide Tray Search:

"patient outcomes"

Slides: 1–12 of 16
Add to tray Remove from tray

Overview: Results for Diagnostic Testing

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: overview | diagnostic testing | immunoassays | sensitivity | specificity
Add to tray Remove from tray

Overview: Conclusions

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: conclusions | diagnostic assays | patient outcomes | prevention | treatment | overview
Add to tray Remove from tray

Comparative Effectiveness of Diagnostic Assays for C.difficile

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: C. difficile Infection (CDI) | cell cytotoxicity assay | immunoassays | toxigenic culture | toxin gene detection | diagnostic assays
Add to tray Remove from tray

Gaps in Knowledge

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: gaps in knowledge | diagnostic assays | prevention strategies | probiotics | prebiotics | fecal transplant | definitions
In the trials that this Comparative Effectiveness Review (CER) was based on, only a few had detailed subanalyses of disease or patient characteristics that correlated with the improved patient outcomes derived from adding an angiotensin-converting enzyme inhibitor (ACEI) or an angiotensin II receptor blocker (ARB) to the treatment regimen of patients with stable ischemic heart disease (IHD) and preserved left ventricular systolic function (LVSF). In addition, harms data were not available for many of the subpopulation analyses. Therefore, this evidence should be used mainly to generate hypotheses. From the subpopulation analyses, it is clear that more evidence is needed to determine whether there are patient characteristics or clinical factors that can determine whether patients with stable IHD and preserved LVSF will benefit more or less from the addition of an ACEI or an ARB to their standard therapies. Gender, diabetic status, the presence or absence of hypertension, the presence or absence of specific concomitant therapies, or a patient’s history of revascularization are all potential factors that may play a role in responsiveness to ACEIs or ARBs. Additional meta-analyses and clinical trials are needed to determine the benefits and harms of ACEIs and ARBs to these different subpopulations of patients.
Add to tray Remove from tray

Gaps in Knowledge About ACEIs and ARBs as Treatment for Stable Ischemic Heart Disease With Preserved Left Ventricular Systolic Function

Presentation: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Patients With Stable Ischemic Heart Disease and Preserved Left Ventricular Systolic Function
Keywords: angiotensin II-receptor blocker | angiotensin-converting enzyme inhibitor | comparative effectiveness | future research | stable ischemic heart disease | gaps in knowledge
Early vs. Late Operative Intervention for Rotator Cuff Tears Earlier operative treatment has been proposed to improve patient outcomes and result in an earlier return to work and decreased costs; therefore, patients face several decisional dilemmas, including whether to opt for early surgical intervention or if and when to forgo nonoperative treatment for operative intervention.
Add to tray Remove from tray

Early vs. Late Operative Intervention for Rotator Cuff Tears

Presentation: Comparative Effectiveness of Nonoperative and Operative Treatments for Rotator Cuff Tears
Keywords: comparative effectiveness | operative intervention | rotator cuff tear | return to work
Comparative Effectiveness or Operative Repair for Rotator Cuff Tears In general, the studies showed few differences in function between interventions. Analysis of comparative studies provided a moderate level of evidence that functional patient outcomes were similar across each of the following surgical interventions: open vs. mini-open; mini-open vs. arthroscopic; open or mini-open vs. arthroscopic; and arthroscopic with or without acromioplasty. The strength of evidence was low for the remaining comparisons examined in the studies, precluding any conclusions regarding their comparative effectiveness.
Add to tray Remove from tray

Comparative Effectiveness or Operative Repair for Rotator Cuff Tears

Presentation: Comparative Effectiveness of Nonoperative and Operative Treatments for Rotator Cuff Tears
Keywords: comparative effectiveness | operative intervention | rotator cuff tear | open repair | mini-open repair | arthroscopic repair | level of evidence
Add to tray Remove from tray

Considerations for Comparisons Across Different Treatment Modalities (3 of 3)

Presentation: Comparator Selection in Observational Comparative Effectiveness Research
Keywords: adherence | provider effects | treatment modalities
Add to tray Remove from tray

Conclusions: Glaucoma Treatment and Visual Impairment or Vision-Related Quality of Life

Presentation: Comparisons of Medical, Laser, and Incisional Surgical Treatments for Open-Angle Glaucoma in Adults
Keywords: glaucoma treatment | vision-related quality of life | visual impairment | visual field loss | optic nerve damage | intraocular pressure
Add to tray Remove from tray

Background

Presentation: Introduction to the User’s Guide for Developing a Protocol for Observational Comparative Effectiveness Research
Keywords: background | comparative effectiveness research | patient-centered outcomes
Add to tray Remove from tray

Clinical Questions Addressed in the CER: Clinical Outcomes of Interest From Treatments

Presentation: Management of Chronic Kidney Disease Stages 1–3
Keywords: clinical outcomes | intermediate outcomes | mortality | end-stage renal disease | quality of life | creatinine | estimated glomerular filtration rate
Add to tray Remove from tray

Noninvasive Technologies for Diagnosing Coronary Artery Disease in Women: Other Findings

Presentation: Noninvasive Technologies for Diagnosing Coronary Artery Disease in Women
Keywords: findings | coronary artery disease | CAD | women | diagnosis | noninvasive technologies | evidence
Pages: [1] 2 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364